New combination strategies may improve patient tolerance to PI3K/mTOR, such as inhibiting PI3K/mTOR pathway only when cancer cells experience radiation-induced stress, which may offer short-term synergistic effects combined with radiotherapy. This evidence concerns the gene MTOR and cancer.